Completed
Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer
NCT02860819
- Conditions
- Endocrine Gland Neoplasms, Endocrine System Diseases, Genital Diseases, +11 more
- Locations
-
- National Cancer Institute Bratislava, Slovakia